Cedric Hermans: How Iis TFPI Inhibition Changing Haemophilia Care?
Cedric Hermans, Head of Haemophilia Centre at the Saint-Luc University Hospital, Brussels, shared a post on LinkedIn:
“How is TFPI inhibition changing haemophilia care?
Join us for the next HaemXcellence live webinar:
TFPI Inhibition in Haemophilia: From Data to Clinical Practice
13 October 2026 | 17:00–18:00 CET
Together with Prof. Yesim Dargaud and Prof. Lorenzo Alberio, I look forward to discussing how the science and clinical data behind TFPI inhibition can be translated into everyday haemophilia practice.
A practical and interactive discussion on where anti-TFPI therapy fits in our rapidly evolving haemophilia treatment landscape.
Registration via the QR code on the invitation below.
Looking forward to the discussion!”
Other posts featuring Cedric Hermans on Hemostasis Today.
-
Sep 15, 2026, 23:35Katya McCarthy: From Lab Specialist to Patient – Facing Polycythemia and Venous Thrombosis
-
Sep 15, 2026, 23:19Narat Srivali: Chronic Preoperative Corticosteroid Use Associated with 51% Higher Postoperative VTE Risk
-
Sep 15, 2026, 23:13Grace M Thomas: Join 3rd edition of the Neutrophil Club of SFI Webinar Series on Thromboinflammation
-
Sep 15, 2026, 23:05Noha K Hashmi: Honoured to Present 2 Case-Based Posters at the 5th MENA Conference for Rare Diseases 2026
-
Sep 15, 2026, 22:56Susan Slingluff Hartmann: How NBDF and the BDRC Are Putting Lived Experience at the Heart of Studies
-
Sep 15, 2026, 22:50Shehab Mohamed: New GCC Consensus Recommendations for the Diagnosis and Management of HLH
-
Sep 15, 2026, 22:42100 Years of von Willebrand Disease: What Has a Century of Progress Taught Us? – EAHAD
-
Sep 15, 2026, 17:33Reza Shojaei: Blood and Plasma Donors Are Not a Production Metric
-
Sep 15, 2026, 17:32Thomas Dayspring: MHT for Vasomotor Symptoms May Also Offer Cardiovascular Benefits